FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891743992> ?p ?o ?g. }

• W2891743992 endingPage "533" @default.
• W2891743992 startingPage "527" @default.
• W2891743992 abstract "Previous study revealed that microRNA (miR)-150 might function as a tumor suppressor in osteosarcoma partially by targeting Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1). The aim of this study was to investigate the clinical significance of miR-150-IGF2BP1 axis in human osteosarcoma which remains unclear. At first, expression levels of miR-150, and IGF2BP1 mRNA and protein in 20 osteosarcoma and matched adjacent noncancerous tissues were respectively detected by quantitative real-time PCR and western blot analyses. Then, subcellular localization and expression pattern of IGF2BP1 protein in 100 osteosarcoma tissues were examined by immunohistochemistry. Associations of miR-150/IGF2BP1 expression with various clinicopathological features and patients’ prognosis were also statistically evaluated. As a result, miR-150 expression was significantly decreased, while IGF2BP1 mRNA and protein expression were dramatically increased in osteosarcoma tissues compared to matched adjacent noncancerous tissues (all P < 0.001). Immunostaining of IGF2BP1 protein was localized in cytoplasm of tumor cells in osteosarcoma tissues. Statistically, low miR-150 expression and/or high IGF2BP1 protein immunoreactive score were all significantly associated with high tumor grade, presence of metastasis and recurrence, as well as poor response to chemotherapy (all P < 0.05). Moreover, miR-150, IGF2BP1 and combined miR-150/IGF2BP1 expressions were all identified as independent prognostic factors for overall and disease-free survivals of osteosarcoma patients (all P < 0.05). In conclusion, our data suggest that miR-150 and its downstream target IGF2BP1 may be a crucial axis for the development, progression and patients’ prognosis of ostesarcoma. The newly identified miR-150/IGF2BP1 axis might be a novel potential therapeutic target for osteosarcoma treatment." @default.
• W2891743992 created "2018-09-27" @default.
• W2891743992 creator A5018037248 @default.
• W2891743992 creator A5020097244 @default.
• W2891743992 creator A5073216396 @default.
• W2891743992 creator A5089805227 @default.
• W2891743992 date "2018-09-15" @default.
• W2891743992 modified "2023-10-12" @default.
• W2891743992 title "Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications" @default.
• W2891743992 cites W1857092002 @default.
• W2891743992 cites W1868799934 @default.
• W2891743992 cites W1967252813 @default.
• W2891743992 cites W1989619850 @default.
• W2891743992 cites W1993192911 @default.
• W2891743992 cites W2000102678 @default.
• W2891743992 cites W2003128235 @default.
• W2891743992 cites W2022753987 @default.
• W2891743992 cites W2024395213 @default.
• W2891743992 cites W2024627520 @default.
• W2891743992 cites W2029213510 @default.
• W2891743992 cites W2065869147 @default.
• W2891743992 cites W2073257981 @default.
• W2891743992 cites W2083930144 @default.
• W2891743992 cites W2134528950 @default.
• W2891743992 cites W2160413016 @default.
• W2891743992 cites W2178308549 @default.
• W2891743992 cites W2181147188 @default.
• W2891743992 cites W2200240897 @default.
• W2891743992 cites W2200948677 @default.
• W2891743992 cites W2239781562 @default.
• W2891743992 cites W2294441425 @default.
• W2891743992 cites W2346946016 @default.
• W2891743992 cites W2412135462 @default.
• W2891743992 cites W2468459975 @default.
• W2891743992 cites W2509100674 @default.
• W2891743992 cites W2513545722 @default.
• W2891743992 cites W2518624608 @default.
• W2891743992 cites W2521569068 @default.
• W2891743992 cites W2556502410 @default.
• W2891743992 cites W2563045617 @default.
• W2891743992 cites W2586437855 @default.
• W2891743992 cites W2588025094 @default.
• W2891743992 cites W2963552158 @default.
• W2891743992 cites W346098014 @default.
• W2891743992 cites W4367435876 @default.
• W2891743992 doi "https://doi.org/10.1007/s12253-018-0454-0" @default.
• W2891743992 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6449306" @default.
• W2891743992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30220021" @default.
• W2891743992 hasPublicationYear "2018" @default.
• W2891743992 type Work @default.
• W2891743992 sameAs 2891743992 @default.
• W2891743992 citedByCount "16" @default.
• W2891743992 countsByYear W28917439922019 @default.
• W2891743992 countsByYear W28917439922020 @default.
• W2891743992 countsByYear W28917439922021 @default.
• W2891743992 countsByYear W28917439922022 @default.
• W2891743992 countsByYear W28917439922023 @default.
• W2891743992 crossrefType "journal-article" @default.
• W2891743992 hasAuthorship W2891743992A5018037248 @default.
• W2891743992 hasAuthorship W2891743992A5020097244 @default.
• W2891743992 hasAuthorship W2891743992A5073216396 @default.
• W2891743992 hasAuthorship W2891743992A5089805227 @default.
• W2891743992 hasBestOaLocation W28917439921 @default.
• W2891743992 hasConcept C104317684 @default.
• W2891743992 hasConcept C105580179 @default.
• W2891743992 hasConcept C121608353 @default.
• W2891743992 hasConcept C142724271 @default.
• W2891743992 hasConcept C145059251 @default.
• W2891743992 hasConcept C153911025 @default.
• W2891743992 hasConcept C173396325 @default.
• W2891743992 hasConcept C204232928 @default.
• W2891743992 hasConcept C2776415932 @default.
• W2891743992 hasConcept C2777760704 @default.
• W2891743992 hasConcept C2779013556 @default.
• W2891743992 hasConcept C4224716 @default.
• W2891743992 hasConcept C502942594 @default.
• W2891743992 hasConcept C54355233 @default.
• W2891743992 hasConcept C71924100 @default.
• W2891743992 hasConcept C86803240 @default.
• W2891743992 hasConceptScore W2891743992C104317684 @default.
• W2891743992 hasConceptScore W2891743992C105580179 @default.
• W2891743992 hasConceptScore W2891743992C121608353 @default.
• W2891743992 hasConceptScore W2891743992C142724271 @default.
• W2891743992 hasConceptScore W2891743992C145059251 @default.
• W2891743992 hasConceptScore W2891743992C153911025 @default.
• W2891743992 hasConceptScore W2891743992C173396325 @default.
• W2891743992 hasConceptScore W2891743992C204232928 @default.
• W2891743992 hasConceptScore W2891743992C2776415932 @default.
• W2891743992 hasConceptScore W2891743992C2777760704 @default.
• W2891743992 hasConceptScore W2891743992C2779013556 @default.
• W2891743992 hasConceptScore W2891743992C4224716 @default.
• W2891743992 hasConceptScore W2891743992C502942594 @default.
• W2891743992 hasConceptScore W2891743992C54355233 @default.
• W2891743992 hasConceptScore W2891743992C71924100 @default.
• W2891743992 hasConceptScore W2891743992C86803240 @default.
• W2891743992 hasIssue "2" @default.
• W2891743992 hasLocation W28917439921 @default.
• W2891743992 hasLocation W28917439922 @default.

• next